All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • sabirnetugPhase 21 trial

    Acumen Pharmaceuticals · Alzheimer Disease

  • SAL-0951SAL-0951 groupPhase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Anemia

  • SAL0137Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Elevated Lipoprotein(a)

  • SAL0150Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM

  • SAL056Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Postmenopausal Women With Osteoporosis

  • SAR402663Phase 21 trial

    Sanofi · Neovascular Age-related Macular Degeneration

  • SAR439459Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • SAR441566Phase 21 trial

    Sanofi · Rheumatoid Arthritis

  • SAR443122Phase 21 trial

    Sanofi · Colitis Ulcerative

  • SAR444336Phase 21 trial

    Sanofi · Microscopic Colitis

  • SAR444836Phase 21 trial

    Sanofi · Phenylketonuria

  • SAR445399Phase 21 trial

    Sanofi · Hidradenitis Suppurativa

  • SAR446268Phase 21 trial

    Sanofi · Myotonic Dystrophy

  • SAR446597Phase 21 trial

    Sanofi · Geographic Atrophy

  • SAR448851Phase 21 trial

    Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease

  • SASS-001Phase 21 trial

    Shionogi · Sleep Apnea

  • SB17170Phase 21 trial

    SPARK Biopharma · IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • SCB-1019TPhase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1022Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCB-1033Phase 21 trial

    Clover Biopharmaceuticals AUS Pty · RSV Infection, Human Metapneumovirus Infection, Parainfluenza Infection

  • SCG101Phase 21 trial

    SCG Cell Therapy Pte. Ltd. · Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent

  • SCG142Phase 21 trial

    SCG Cell Therapy Pte. Ltd. · HPV-Related Squamous Cell Carcinoma, HPV-Related Cervical Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma

  • SCI-110Phase 21 trial

    Neurothera Labs Inc. · Tourette Syndrome

  • scp776allPhase 21 trial

    Silver Creek Pharmaceuticals · Acute Ischemic Stroke (AIS)

  • SCT520FFPhase 21 trial

    Sinocelltech Ltd. · nAMD

  • SCT650CPhase 21 trial

    Sinocelltech Ltd. · Hidradenitis Suppurativa (HS)

  • SCTT11Phase 21 trial

    Sinocelltech Ltd. · TED

  • SCTV02Phase 21 trial

    Sinocelltech Ltd. · Respiratory Syncytial Virus

  • SCTV04CRecombinant Herpes Zoster Vaccine -DosePhase 21 trial

    Sinocelltech Ltd. · Herpes Zoster

  • TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)

  • Sequential EpirubicinPhase 21 trial

    RemeGen Co., Ltd. · Breast Cancer

  • SFG-02Phase 21 trial

    Juro Sciences Inc. · Participants With Underactive Bladder (UAB)

  • SFL-0821Phase 21 trial

    Soufflé Therapeutics, Inc. · Facioscapulohumeral Muscular Dystrophy (FSHD)

  • SG1827Phase 21 trial

    Hangzhou Sumgen Biotech Co., Ltd. · Advanced Solid Tumors

  • SG2918Phase 21 trial

    Hangzhou Sumgen Biotech Co., Ltd. · Relapsed/Refractory Multiple Myeloma

  • SGX-001Phase 21 trial

    Somagenetix AG · Chronic Granulomatous Disease (CGD)

  • SHR-1681Phase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors

  • SHR-2017Phase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors

  • SHR-3045Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Active Rheumatoid Arthritis

  • SHR-3276Phase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors

  • SHR-4298Phase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors

  • SHR-4394Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • SHR-4602Phase 21 trial

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors

  • SHR-4642Phase 21 trial

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors

  • SHR-7367Phase 21 trial

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Solid Tumor

  • SHR-8203Phase 21 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Solid Tumors

  • SHR-9803Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Solid Tumors

  • SHR3680Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • SHR4597Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma

  • SIM0278Phase 21 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)

NewerPage 68 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.